Loading...
NPI 1033655303 · Deerfield Beach, FL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Clarity Lab Solutions, LLC is a clinical medical laboratory provider located in Deerfield Beach, Florida. This profile covers 23 Medicare and 39 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Clarity Lab Solutions, LLC |
| Address | 1701 Green Rd Ste A |
| City | Deerfield Beach |
| State | FL |
| ZIP | 33064 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | January 11, 2017 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $2.5M |
| Medicare | $899.1K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
23 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 7,250 | $30 | $246.5K |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 2,100 | $70 | $144.8K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 2,700 | $30 | $91.9K |
| 87651 | The lab analyst performs a test for the bacteria Streptococcus, group A, using amplified nucleic acid probe technique. Strep A commonly causes acute pharyngitis, or strep throat. | 1,690 | $30 | $57.6K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 1,690 | $30 | $57.6K |
| 87500 | The lab analyst performs a test for vancomycin resistance in an infectious organism’s nucleic acid using amplified probe technique. VRE, vancomycin resistant enterococcus, is the most common organism… | 1,670 | $30 | $56.7K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 1,280 | $30 | $43.5K |
| 87482 | The lab analyst performs a test to quantify infection with Candida species using nucleic acid probe technique. | 530 | $60 | $28.9K |
| 87637 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, influenza B, and respiratory syncytial virus (RSV)… | 200 | $140 | $27.6K |
| 87799 | The lab analyst performs a test to quantify infection with an infectious agent, not otherwise specified in another code, using a nucleic acid probe technique. Use this code if you know the laboratory… | 600 | $40 | $25.1K |
Showing 1–10 of 23
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
23 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87798 | 15 | 110 | 590 | $30 | $218.6K |
| 87150 | 38 | 40 | 1,660 | $30 | $173.2K |
| 87801 | 9 | 60 | 450 | $70 | $166.5K |
| 87481 | 10 | 80 | 340 | $30 | $72.8K |
| 87799 | 5 | 10 | 600 | $40 | $46.2K |
| 87640 | 10 | 70 | 210 | $30 | $30.9K |
| 87653 | 7 | 70 | 180 | $30 | $30.8K |
| 87500 | 8 | 70 | 190 | $30 | $29.6K |
| 87482 | 1 | 10 | 530 | $50 | $28.7K |
| 87563 | 6 | 30 | 180 | $30 | $22.9K |
Showing 1–10 of 23
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
39 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 38,720 | $30 | $1.3M |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 7,570 | $40 | $265K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 49,060 | $10 | $245.3K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 9,100 | $20 | $209.3K |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen… | 8,410 | $10 | $100.9K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 16,170 | $1 | $64.7K |
| 87799 | The lab analyst performs a test to quantify infection with an infectious agent, not otherwise specified in another code, using a nucleic acid probe technique. Use this code if you know the laboratory… | 6,490 | $10 | $45.4K |
| 87900 | The lab analyst measures a patient’s susceptibility or resistance to drugs aimed at a virus. The test predicts the behavior of the phenotype based on comparing patient data to regularly updated… | 1,860 | $20 | $35.3K |
| 87486 | The lab analyst performs a test for Chlamydia pneumoniae using amplified nucleic acid probe technique. Chlamydia pneumoniae also known as TWAR, Taiwan Acute Respiratory agent, commonly causes mild… | 9,610 | $1 | $28.8K |
| 87581 | The lab analyst performs a test for Mycoplasma pneumonia, a bacteria, using amplified nucleic acid probe technique. | 9,440 | $1 | $28.3K |
Showing 1–10 of 39
How this provider's Medicaid billing volume and revenue compare to other Florida providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Florida median
39 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 11 | 320 | 750 | $40 | $232.7K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 11 | 70 | 500 | $30 | $231.8K |
| 87482 | The lab analyst performs a test to quantify infection with Candida species using nucleic acid probe technique. | 3 | 10 | 4,300 | $20 | $140.7K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 13 | 160 | 450 | $50 | $115.7K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 241 | 340 | 720 | $10 | $100.6K |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 9 | 90 | 320 | $20 | $100.3K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 39 | 80 | 240 | $10 | $92.2K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 59 | 110 | 490 | $40 | $64.4K |
| 87632 | The lab analyst performs a test to identify a respiratory virus using an amplified nucleic acid probe technique. He may also use the multiplex reverse transcription technique. The provider does this… | 5 | 10 | 610 | $60 | $61.6K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 236 | 330 | 690 | $10 | $61.6K |
Showing 1–10 of 39
Other providers in the same ZIP code as Clarity Lab Solutions, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Fi-broward Nursing, LLC | FL | Skilled Nursing Facility | $0 | $14.5M |
| Prima Food Corp | FL | Home Delivered Meals | $0 | $11.4M |
| Affinity Home Care Inc. | FL | Attendant Care Provider | $0 | $10.7M |
| North Broward Hospital District | FL | General Acute Care Hospital | $0 | $10.5M |
| Marmed, Inc. | FL | Durable Medical Equipment & Medical Supplies | $0 | $8.8M |
| Aker Kasten Eye Center | FL | Ophthalmology Physician | $1M | $0 |
| Paul Rodriguez | FL | Pain Medicine Physician | $884.5K | $0 |
| Todd Kupferman | FL | Otolaryngology Physician | $564.1K | $0 |
| Shailesh Gupta | FL | Retina Specialist (Ophthalmology) Physician | $508.1K | $43.1K |
| Rand Surgical Pavillion Corp | FL | Ambulatory Surgical Clinic/Center | $531.5K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.